Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

This study is currently recruiting participants.
Verified February 2014 by Stanford University
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00230308
First received: September 28, 2005
Last updated: February 12, 2014
Last verified: February 2014
  Purpose

Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.


Condition
Head and Neck Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

Resource links provided by NLM:


Further study details as provided by Stanford University:

Biospecimen Retention:   Samples With DNA

At the time of biospy or surgery, a small amount of tumor tissue (approximately 1 cc) will be taken from the main tumor specimen and stored until analysis.


Estimated Enrollment: 500
Study Start Date: April 2002
Estimated Study Completion Date: December 2024
Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients undergoing surgery at Stanford University for head and neck cancer.

Criteria

Inclusion Criteria:

All patients undergoing surgery at Stanford University for head and neck cancer.

Exclusion Criteria:

Non-Stanford patients.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00230308

Contacts
Contact: Cato Chan 650-724-4606 catochan@stanford.edu

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Brindha Bavan    650-725-4777    brindhas@stanford.edu   
Contact: Cancer Clinical Trials Office    (650) 498-7061      
Principal Investigator: Quynh-Thu Le         
Sub-Investigator: Willard E Fee Jr         
Sub-Investigator: Zijie Sun         
Sub-Investigator: Jan Matthijs van de Rijn         
Sub-Investigator: Dr Michael Kaplan         
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Quynh-Thu Le Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00230308     History of Changes
Other Study ID Numbers: ENT0008, 76537, ENT0008, 11402
Study First Received: September 28, 2005
Last Updated: February 12, 2014
Health Authority: United States: Food and Drug Administration
United States: Institutional Review Board

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms

ClinicalTrials.gov processed this record on April 15, 2014